ABC | Volume 113, Nº2, Agosto 2019

Artigo Original Oliveira et al Risco cardiovascular na psoríase Arq Bras Cardiol. 2019; 113(2):242-249 1. Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol. 2001;15(1):16-7. 2. KimWB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278-85. 3. Ayala-FontánezN,SolerDC,McCormickTS.Currentknowledgeonpsoriasis and autoimmune diseases. Psoriasis (Auckl). 2016 Feb;6:7-32. 4. Duarte GV, Porto-Silva L, de Oliveira MF. Epidemiology and treatment of psoriasis: a Brazilian perspective. Psoriasis (Auckl). 2015 Apr;5:55-64. 5. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263-71. 6. Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014-24. 7. Miller IM, Skaaby T, Ellervik C, Jemec GB. Quantifying cardiovascular disease risk factors in patients with psoriasis: ameta-analysis. Br J Dermatol. 2013;169(6):1180-7. 8. OgdieA,SchwartzmanS,EderL,MaharajAB,ZismanD,RaychaudhuriSP,et al. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations. J Rheumatol. 2014;41(11):2315-22. 9. Mehta NN, Azfar RS, ShinDB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J. 2010;31(8):1000-6. 10. Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015;241(2):507-32. 11. Takimura CK, Lemos PA, Perin MA, da Silva EE, Ambrose J, Ramires JA, et al. Angiographic geometric predictors of myocardial infarction are not associated with ultrasonographic markers of plaque vulnerability. Arq Bras Cardiol. 2006;87(2):99-105. 12. Malachias MV, Ferreira S, Souza WK, Ribeiro JM, Miranda RD, Jardim TS. 7th Brazilian Guideline of Arterial Hypertension: Chapter 11 - Arterial Hypertension in the elderly. Arq Bras Cardiol. 2016;107(3 Suppl 3):64-6. 13. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253. 14. Faludi AA, Izar MC, Saraiva JF, Chacra AP, Bianco HT, Afiune A, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017;109(2 Suppl 1):1-76. 15. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95. 16. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210(3):194-9. 17. Siqueira AL, Sakurai E, SouzaMCFM. Dimensionamento de amostragemem estudos clínicos e epidemiológicos. 1 ed. Salvador: Associação Brasileira de Estatística (ABE), 2001. p.126. 18. Rondina RD, Gorayeb R, Botelho C, Silva AM. A Relação entre Tabagismo e Características Socio-Demográficas em Universitários. Psic, Saúde & Doenças. 2005 Jul;6:35-45. 19. World Health Organization. (WHO). Global status report: alcohol policy. Geneva; 2004. 20. AmericanDiabetes Association. 2. Classification andDiagnosis of Diabetes. Diabetes Care. 2018;41(Suppl 1):S13-27. 21. Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. 22. Hametner B, Wassertheurer S, Kropf J, Mayer C, Eber B, Weber T. Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements. Blood Press Monit. 2013;18(3):173-6. 23. Weber T,Wassertheurer S, RammerM, Maurer E, Hametner B, Mayer CC, et al. Validation of a brachial cuff-based method for estimating central systolic blood pressure. Hypertension. 2011;58(5):825-32. 24. Nunan D, Wassertheurer S, Lasserson D, Hametner B, Fleming S, Ward A, et al. Assessment of central haemomodynamics from a brachial cuff in a community setting. BMC Cardiovasc Disord. 2012;12:48. 25. Freire CM, Alcantara ML, Santos SN, Veloso O, Porto CLL, Barros MV, et al. Recomendaço para a Quantificaço pelo Ultrassom da Doenca Aterosclerotica das Arterias Carotidas e Vertebrais: Grupo de Trabalho do Departamento de Imagem Cardiovascular da Sociedade Brasileira de Cardiologia – DIC - SBC. Arq Bras Cardiol: Imagem cardiovasc. 2015 Abril; 28:e1- 64 26. Aquino EM, Barreto SM, Bensenor IM, Carvalho MS, Chor D, Duncan BB, et al. Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design. Am J Epidemiol. 2012;175(4):315-24. 27. Polak JF, Pencina MJ, O’Leary DH, D’Agostino RB. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke. 2011;42(11):3017-21. 28. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. 29. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321-60. 30. Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009;160(5):1048-56. 31. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410-22. 32. KetelhuthDF, HanssonGK. Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against disease. Circ J. 2015;79(5):924-33. 33. Coban M, Tasli L, Turgut S, Özkan S, Tunç Ata M, Akın F. Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris. Ann Dermatol. 2016;28(1):74-9. 34. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann RheumDis. 2010;69(7):1310-4. 35. Soeiro AM, Haddad M, de Almeida MC, Ruppert AD, Serrano CV. Rheumatoid arthritis and cardiovascular disease: what is known about this relationship and what can currently be done for affected patients? Rev Port Cardiol. 2012;31(3):225-32. 36. Urruela MA, Suarez-Almazor ME. Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies. Curr Rheumatol Rep. 2012;14(5):428-37. 37. Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford). 2010;49(2):295-307. Referências 248